Literature DB >> 15731480

Adiponectin and coronary heart disease: the Strong Heart Study.

Robert S Lindsay, Helaine E Resnick, Jianhui Zhu, Min L Tun, Barbara V Howard, Ying Zhang, Jeunliang Yeh, Lyle G Best.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15731480     DOI： 10.1161/01.ATV.0000153090.21990.8c

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  41 in total

1.  Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women.

Authors:  George A King; Sarah E Deemer; Dixie L Thompson
Journal:  Acta Diabetol       Date:  2010-05-08       Impact factor: 4.280

2.  Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women.

Authors:  Tobias Pischon; Frank B Hu; Cynthia J Girman; Nader Rifai; JoAnn E Manson; Kathryn M Rexrode; Eric B Rimm
Journal:  Atherosclerosis       Date:  2011-07-20       Impact factor: 5.162

Review 3.  Novel metabolic biomarkers of cardiovascular disease.

Authors:  Majken K Jensen; Monica L Bertoia; Leah E Cahill; Isha Agarwal; Eric B Rimm; Kenneth J Mukamal
Journal:  Nat Rev Endocrinol       Date:  2014-09-02       Impact factor: 43.330

Review 4.  Adiponectin actions in the cardiovascular system.

Authors:  Teresa A Hopkins; Noriyuki Ouchi; Rei Shibata; Kenneth Walsh
Journal:  Cardiovasc Res       Date:  2006-10-20       Impact factor: 10.787

5.  Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study.

Authors:  Masumi Ai; Seiko Otokozawa; Bela F Asztalos; Charles C White; L Adrienne Cupples; Katsuyuki Nakajima; Stefania Lamon-Fava; Peter W Wilson; Yuji Matsuzawa; Ernst J Schaefer
Journal:  Atherosclerosis       Date:  2011-06-12       Impact factor: 5.162

Review 6.  New and emerging biomarkers in cardiovascular disease.

Authors:  Leah E Cahill; Monica L Bertoia; Sarah A Aroner; Kenneth J Mukamal; Majken K Jensen
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

Review 7.  Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.

Authors:  José J Fuster; Noriyuki Ouchi; Noyan Gokce; Kenneth Walsh
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

Review 8.  Adiponectin, driver or passenger on the road to insulin sensitivity?

Authors:  Risheng Ye; Philipp E Scherer
Journal:  Mol Metab       Date:  2013-04-19       Impact factor: 7.422

9.  Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome.

Authors:  Matthew R Smith; Hang Lee; Francis McGovern; Mary Anne Fallon; Melissa Goode; Anthony L Zietman; Joel S Finkelstein
Journal:  Cancer       Date:  2008-05-15       Impact factor: 6.860

Review 10.  Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors.

Authors:  Matthew R Smith
Journal:  Curr Urol Rep       Date:  2008-05       Impact factor: 3.092
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.